Qianben Wang Laboratory: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
(16 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
<div style="padding: 20px; color: #ffffff; background-color: | <div style="padding: 20px; color: #ffffff; background-color: mediumBlue; width: 900px"> | ||
<center><font face="lucida fax" style= "color: | <center><font face="lucida fax" style= "color:Yellow" size="+10">'''Qianben Wang Laboratory'''</font> | ||
</center> | </center> | ||
<br> | <br> | ||
<center><font face="lucida fax" style= "color: | <center><font face="lucida fax" style= "color:Yellow" size="+2">'''Laboratory of Cancer Epigenomics'''</font></center> | ||
<br> | |||
<center><font face="lucida fax" style= "color:Yellow" size="+1">'''Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University'''</font> | |||
<br> | <br> | ||
[[Wang | <font face="lucida fax" style="color:#ffffff" size="+1"> '''Home''' </font>]] | [[Wang | <font face="lucida fax" style="color:#ffffff" size="+1"> '''Home''' </font>]] | ||
[[Wang:Research | <font face="lucida fax" style="color:#ffffff" size="+1"> '''Research''' </font>]] | [[Wang:Research | <font face="lucida fax" style="color:#ffffff" size="+1"> '''Research''' </font>]] | ||
Line 17: | Line 18: | ||
<table border="4" color="mediumblue"> | <table border="4" color="mediumblue"> | ||
<td width="926"> | <td width="926"> | ||
[[Image: | [[Image:exo.tif]] | ||
<div style="text-align:left" font face="lucia fax">''' | <div style="text-align:left" font face="lucia fax">'''The schematic diagram of androgen receptor binding element (ARBE)-directed AR transcriptional regulation. Upper panel shows that agonist-bound AR (red) recognizes an agonist-ARBE in an agonist-specific manner, whereas the bottom panel indicates that antagonist-bound AR (blue) binds to an antagonist-ARBE in an antagonist-dependent manner. The binding of AR to two distinctly different motifs leads to distinct transcriptional outcomes in prostate cancer. The crystal structures of the DNA binding domain (DBD), dihydrotestosterone-ligand binding domain (DHT-LBD) and bicalutamide-LBD are modified from 1R4I, 1T7T and 1Z95, respectively. | ||
</div> | </div> | ||
</td> | </td> | ||
</table> | </table> |
Revision as of 14:11, 23 December 2014
The schematic diagram of androgen receptor binding element (ARBE)-directed AR transcriptional regulation. Upper panel shows that agonist-bound AR (red) recognizes an agonist-ARBE in an agonist-specific manner, whereas the bottom panel indicates that antagonist-bound AR (blue) binds to an antagonist-ARBE in an antagonist-dependent manner. The binding of AR to two distinctly different motifs leads to distinct transcriptional outcomes in prostate cancer. The crystal structures of the DNA binding domain (DBD), dihydrotestosterone-ligand binding domain (DHT-LBD) and bicalutamide-LBD are modified from 1R4I, 1T7T and 1Z95, respectively.
|